Physician profile
Matrika Johnson
NPI 1700809035
$1,809.97
in general payments reported to CMS, 2019-2025
15 companies · $201 in 2025
The $201 reported for 2025 was more than what a typical Reproductive Endocrinology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $508 · 2020: $127 · 2021: $207 · 2022: $186 · 2023: $235 · 2024: $347 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $743 · Education: $39.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $743.28 |
| Education | $39.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $551.86 | 2019-2024 | |
| Ferring Pharmaceuticals INC. | $295.38 | 2019-2025 | Menopur |
| Abbvie INC. | $276.83 | 2019-2024 | |
| Channel Medsystems, INC. | $148.83 | 2025 | |
| Coopersurgical, INC. | $130.16 | 2021-2025 | Stripper |
| Myriad Women'S Health, INC. | $101.76 | 2023 | |
| Lupin INC. | $99.29 | 2019 | |
| Galen US INC | $85.66 | 2019 | |
| Myovant Sciences INC. | $23.79 | 2022 | |
| Merck Sharp & Dohme LLC | $19.27 | 2019 | |
| Therapeuticsmd, INC. | $18.18 | 2022 | |
| Virtus Pharmaceuticals LLC | $16.49 | 2021 | |
| Organon LLC | $16.33 | 2021 | |
| Medline Industries Lp | $13.55 | 2023 | |
| Mission Pharmacal Company | $12.59 | 2024 | Citranatal Medley |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matrika Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.